PDF(Pubmed)
Abstract：
Gout is one of the most common noncommunicable diseases in Hong Kong. Although effective treatment options are readily available, the management of gout in Hong Kong remains suboptimal. Like other countries, the treatment goal in Hong Kong usually focuses on relieving symptoms of gout but not treating the serum urate level to target. As a result, patients with gout continue to suffer from the debilitating arthritis, as well as the renal, metabolic, and cardiovascular complications associated with gout. The Hong Kong Society of Rheumatology spearheaded the development of these consensus recommendations through a Delphi exercise that involved rheumatologists, primary care physicians, and other specialists in Hong Kong. Recommendations on acute gout management, gout prophylaxis, treatment of hyperuricemia and its precautions, co-administration of non-gout medications with urate-lowering therapy, and lifestyle advice have been included. This paper serves as a reference guide to all healthcare providers who see patients who are at risk and are known to have this chronic but treatable condition.
摘要：
痛风是香港最常见的非传染性疾病之一。虽然有效的治疗方案是现成的，香港痛风的管理仍然欠佳。和其他国家一样,香港的治疗目标通常集中在缓解痛风症状，而不是将血清尿酸水平治疗至目标。因此,痛风患者继续患有衰弱性关节炎，以及肾脏，新陈代谢，与痛风相关的心血管并发症。香港风湿病学会通过有风湿病学家参与的德尔菲练习，率先制定了这些共识建议，初级保健医生，以及香港的其他专家。关于急性痛风管理的建议，痛风预防,高尿酸血症的治疗及其预防措施，非痛风药物与降尿酸治疗的共同给药，和生活方式建议已经包括在内。本文可作为所有医疗服务提供者的参考指南，他们看到有风险的患者，并且已知患有这种慢性但可治疗的疾病。
